Literature DB >> 22468968

Hypertensive retinopathy: incidence, risk factors, and comorbidities.

Sacide Erden1, Ercan Bicakci.   

Abstract

We aimed to determine the prevalence and risk factors of retinopathy in hypertensive outpatients. Demographic data, accompanying diseases, anthropometric measurements, and blood and urine biochemistry of 655 hypertensive patients were evaluated. Hypertensive retinopathy rate was 66.3% (grade 1, 33.6%; grade 2, 32.7%). Age, duration of hypertension, and systolic blood pressure levels were significant risk factors for retinopathy (P = .048, P = .035, and P = .012, respectively). Any correlations between retinopathy and gender, body mass index, biochemistry, and associated diseases were not found. This study shows that the degree and duration of hypertension increases the incidence of retinopathy. Low-grade retinopathy seems not to be associated with other cardiovascular risks.

Entities:  

Mesh:

Year:  2012        PMID: 22468968     DOI: 10.3109/10641963.2012.663028

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  13 in total

1.  Alterations of Ocular Hemodynamics Impair Ophthalmic Vascular and Neuroretinal Function.

Authors:  Shu-Huai Tsai; Wankun Xie; Min Zhao; Robert H Rosa; Travis W Hein; Lih Kuo
Journal:  Am J Pathol       Date:  2018-01-05       Impact factor: 4.307

2.  Serous retinal detachment in preeclampsia and malignant hypertension.

Authors:  Christopher Seungkyu Lee; Eun Young Choi; Minsub Lee; Heesuk Kim; Hyewon Chung
Journal:  Eye (Lond)       Date:  2019-05-14       Impact factor: 3.775

3.  Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension.

Authors:  S A M Kolman; A M van Sijl; F A van der Sluijs; M A van de Ree
Journal:  J Hum Hypertens       Date:  2016-07-28       Impact factor: 3.012

4.  Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy.

Authors:  Ecaterina Pavlovschi; Valeriana Pantea; Djina Borovic; Olga Tagadiuc
Journal:  Med Pharm Rep       Date:  2021-04-29

5.  Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients.

Authors:  Nelly N Kabedi; Jean-Claude Mwanza; François B Lepira; Tharcisse K Kayembe; David L Kayembe
Journal:  Cardiovasc J Afr       Date:  2014 Sep-Oct       Impact factor: 1.167

Review 6.  Eclectic Ocular Comorbidities and Systemic Diseases with Eye Involvement: A Review.

Authors:  María D Pinazo-Durán; Vicente Zanón-Moreno; José J García-Medina; J Fernando Arévalo; Roberto Gallego-Pinazo; Carlo Nucci
Journal:  Biomed Res Int       Date:  2016-03-14       Impact factor: 3.411

7.  Relationship between retinopathy and renal abnormalities in black hypertensive patients.

Authors:  A B Omotoso; P M Kolo; T O Olanrewaju; J F Owoeye; S A Biliaminu; V A Olatunji
Journal:  Clin Hypertens       Date:  2016-10-21

8.  Microalbuminuria and Retinopathy among Hypertensive Nondiabetic Patients at a Large Public Outpatient Clinic in Southwestern Uganda.

Authors:  Peter Kangwagye; Joselyn Rwebembera; Tony Wilson; Francis Bajunirwe
Journal:  Int J Nephrol       Date:  2018-06-06

9.  Effect of advanced nursing care on psychological disorder in hypertensive retinopathy of pregnancy: A protocol of systematic review.

Authors:  Xiao-Fang Wang; Lin-Juan Liu
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

Review 10.  Galectins in the Pathogenesis of Common Retinal Disease.

Authors:  Bruna Caridi; Dilyana Doncheva; Sobha Sivaprasad; Patric Turowski
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.